Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03132675
What this trial is testing

Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment

Who this might be right for
Stage III/IV Melanoma
OncoSec Medical Incorporated 143
Early research (Phase 1)WithdrawnNCT00803374
What this trial is testing

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Testing effectiveness (Phase 2)WithdrawnNCT01851408
What this trial is testing

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Who this might be right for
MelanomaRecurrent MelanomaStage III Melanoma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00289640
What this trial is testing

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 210
Early research (Phase 1)Active Not RecruitingNCT03311308
What this trial is testing

A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma

Who this might be right for
Advanced Melanoma
Yana Najjar 23
Testing effectiveness (Phase 2)UnknownNCT05097378
What this trial is testing

Perioperative Encobini in BRAFV600 Mutant Stage III (B/C/D) or Oligometastatic Stage IV Melanoma

Who this might be right for
MelanomaCancer
CCTU- Cancer Theme 45
Testing effectiveness (Phase 2)Study completedNCT02009397
What this trial is testing

A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients

Who this might be right for
Metastatic Melanoma
University of Louisville 27
Not applicableLooking for participantsNCT06199713
What this trial is testing

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

Who this might be right for
MelanomaMelanoma Stage IIIMelanoma Stage IV+1 more
University of Wisconsin, Madison 24
Early research (Phase 1)Study completedNCT01489059
What this trial is testing

Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 42
Early research (Phase 1)Active Not RecruitingNCT02721459
What this trial is testing

XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma

Who this might be right for
MelanomaSkin Cancer
H. Lee Moffitt Cancer Center and Research Institute 26
Large-scale testing (Phase 3)Looking for participantsNCT07068074
What this trial is testing

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Who this might be right for
Cutaneous Melanoma
ECOG-ACRIN Cancer Research Group 428
Testing effectiveness (Phase 2)Active Not RecruitingNCT04708418
What this trial is testing

A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Melanoma of Unknown PrimaryRecurrent Cutaneous Melanoma
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Ended earlyNCT00505635
What this trial is testing

Biochemotherapy With Temozolomide for Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03767348
What this trial is testing

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Microsatellite Instability-High (MSI-H)Non-melanoma Skin Cancer (NMSC)+1 more
Replimune, Inc. 340
Early research (Phase 1)Study completedNCT02434354
What this trial is testing

A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma

Who this might be right for
Malignant Melanoma
Abramson Cancer Center at Penn Medicine 33
Large-scale testing (Phase 3)Study completedNCT05297565
What this trial is testing

Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Complete Resection

Who this might be right for
Melanoma
Bristol-Myers Squibb 14
Large-scale testing (Phase 3)Looking for participantsNCT06246149
What this trial is testing

Adjuvant Tebentafusp in High Risk Ocular Melanoma

Who this might be right for
Uveal Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 290
Not applicableActive Not RecruitingNCT02385214
What this trial is testing

MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma by AJCC V7 Stage
Melanoma and Skin Cancer Trials Limited 400
Early research (Phase 1)Study completedNCT00112229
What this trial is testing

Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients

Who this might be right for
Melanoma
Centre Hospitalier Universitaire Vaudois 29
Next Page